sidebar










This website copyright 2007
AIDS Vaccine Advocacy Coalition

Site Design:
Canfield Design Studios, Inc.



PrEP Watch


What's New

What's new in PrEP research and advocacy? Click on the links below!

-- Jagged Little Pills
POZ Magazine
June 2007

Some drugs approved to treat HIV may also protect people not infected with HIV if taken before they engage in high-risk activities. Then why has it been so difficult to conduct the necessary studies to prove—or disprove—the theory?... click here to read more

-- Tenofovir Disoproxil Fumarate for Prevention of HIV Infection in Women: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Trial
PLoS Clinical Trials
25 May 2007
Published results of Family Health International's study of TDF in women in West Africa ... click here to read more

-- Botswana: Botusa Conducts Truvada Clinical Trials
Mmegi/The Reporter (Gaborone)
8 May 2007

BOTUSA is conducting clinical trials to see whether Truvada, a combination of two anti-retroviral (ARV) drugs, taken daily can prevent HIV infection.
The trials that are being conducted in Gaborone and Francistown, target young Batswana adults, aged 18 to 29 who are not infected by HIV... click here to read more

-- Narrative Review: Antiretroviral Therapy to Prevent the Sexual Transmission of HIV-1
Annals of Internal Medicine
17 April 2007 | Volume 146 Issue 8 | Pages 591-601
Antiretroviral therapy (ART) has prolonged and improved the lives of persons infected with HIV. Theoretically, it can also be used to prevent the transmission of HIV.... click here to read more



HOME • CONTACT US
 

What's New

The Basics

PrEP Science

PrEP Clinical Trials

Advocacy, Policy & Community

Meeting Reports

Links